Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05YUI
|
||||
Former ID |
DIB000968
|
||||
Drug Name |
Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy
|
||||
Synonyms |
Adenosine deaminase-transduced hematopoietic stem cell therapy; Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy (ADA-SCID)
|
||||
Indication | Immunodeficiency [ICD9: 279.3; ICD10:D84.9] | Phase 1/2 | [551929] | ||
Company |
San Raffaele Telethon Institute for Gene Therapy
|
||||
Target and Pathway | |||||
Target(s) | Adenosine deaminase | Target Info | Modulator | [551928] | |
NetPath Pathway | TCR Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PANTHER Pathway | Adenine and hypoxanthine salvage pathway | ||||
PathWhiz Pathway | Purine Metabolism | ||||
Reactome | Purine salvage | ||||
WikiPathways | Metabolism of nucleotides | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.